/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Cognitive function and adherence to treatment in patients with chronic heart failure and reduced left ventricular ejection fraction: relation and prognostic meaning
Event: ESC Congress 2019
Topic: Comorbidities
Session: Heart failure: aspects of aging and cognition
New disease-specific adherence questionnaire can predict 2-year survival in chronic heart failure
Event: ESC Congress 2019
Topic: Comorbidities
Session: Heart failure management
Prognostic value of cognitive tests in chronic heart failure with reduced left ventricular ejection fraction
Event: Heart Failure 2019
Topic: Comorbidities
Session: Chronic Heart Failure - Clinical
Predictors of cognitive impairment in patients with chronic heart failure and reduced left ventricular ejection fraction
Event: Heart Failure 2019
Topic: Comorbidities
Session: Chronic Heart Failure - Clinical
Meldonium and gamma-butyrobetaine combination improves cognitive function and flow-mediated vasodilatory response in chronic systolic heart failure: the results of open-label pilot study.
Event: Heart Failure 2018
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
Cognitively impaired versus cognitively non-impaired chronic heart failure patients: which distinctions?
Event: Heart Failure 2018
Topic: Comorbidities
Session: Chronic Heart Failure - Clinical
ESC 365 is supported by
